Jennifer M. Eatrides

Hematology | Oncology

4101 Jim Walter Blvd
Tampa, FL 33607

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Management of Recurrent Venous Thromboembolism on Anticoagulation.

Management of Recurrent Venous Thromboembolism on Anticoagulation.

Journal: Journal of clinical medicine

Published: March 06, 2026

Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia Vera.

Impact of Phlebotomy on Quality of Life in Low-Risk Polycythemia Vera.

Journal: Journal of clinical medicine

Published: June 23, 2024

Autologous Hematopoietic Cell Transplantation Consolidation for First Response is Associated With Longer Survival Among Patients With Nodal Peripheral T Cell Lymphoma.

Autologous Hematopoietic Cell Transplantation Consolidation for First Response is Associated With Longer Survival Among Patients With Nodal Peripheral T Cell Lymphoma.

Journal: Transplantation and cellular therapy

Published: March 15, 2024

Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective study.

Complement-mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective study.

Journal: European journal of haematology

Published: July 25, 2023

Can we lower the platelet threshold of ≥ 50 × 109/L for performing a lumbar puncture safely in patients with hematological malignancies?

Can we lower the platelet threshold of ≥ 50 × 109/L for performing a lumbar puncture safely in patients with hematological malignancies?

Journal: Annals of hematology

Published: July 24, 2022

CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia.

CPX-351 Yields Similar Response and Survival Outcome in Younger and Older Patients With Secondary Acute Myeloid Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 17, 2022

Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution.

Post Approval Experience with Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura at a Single Institution.

Journal: Journal of clinical medicine

Published: May 15, 2021

Pancytopenia and Profound Neutropenia as a Sequela of Severe SARS-CoV-2 Infection (COVID-19) With Concern for Bone Marrow Involvement.

Pancytopenia and Profound Neutropenia as a Sequela of Severe SARS-CoV-2 Infection (COVID-19) With Concern for Bone Marrow Involvement.

Journal: Open forum infectious diseases

Published: November 11, 2020

A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancer.

A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancer.

Journal: Medical oncology (Northwood, London, England)

Published: June 26, 2020

Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma.

Neoadjuvant BRAF-targeted therapy in regionally advanced and oligometastatic melanoma.

Journal: Pigment cell & melanoma research

Published: May 25, 2019

Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma.

Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: October 05, 2017

Serum albumin as a stable predictor of prognosis during initial treatment in patients with diffuse large B cell lymphoma.

Serum albumin as a stable predictor of prognosis during initial treatment in patients with diffuse large B cell lymphoma.

Journal: Annals of hematology

Published: June 19, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026